Browse By: Country ι Category ι Tag
Home  »  Gastric Cancer

Gastric Cancer Market Research Reports

More

Frontier Pharma: Gastric Cancer - Early Stage Pipeline Innovation Shows Shift Towards Targeted mAbs
Gastric cancer is the fifth most common cancer globally, and due to its indolent nature remains one of the most common causes of cancer-related death worldwide.
Published Date: Mar 2016
Published By: GBI Research

Price: $6995
Dysphagia Global Clinical Trials Review, H1, 2013
Dysphagia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Dysphagia Global Clinical Trials Review, H1, 2013" provides data on the Dysphagia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dysphagia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dysphagia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house anal
Published Date: Apr 2013
Published By: GlobalData

Price: $2500
Tesetaxel (Gastric Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Tesetaxel (Gastric Cancer) Analysis and Forecasts to 2020 provides Tesetaxel sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Gastric Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Herceptin (Gastric Cancer) -Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Herceptin (Gastric Cancer)-Analysis and Forecasts to 2020 provides Herceptin sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2010-2020). The report also includes information on Oncology's Disease market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope T
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Tykerb (Gastric Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Tykerb (Gastric Cancer) - Analysis and Forecasts from 2012 to 2020 provides Tykerb sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2012-2020). The report also includes information on Oncology's Disease market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
S-1 (Gastric Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, S-1 (Gastric Cancer) - Analysis and Forecasts to 2020 provides S-1 sales estimates for EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Oncology's Disease market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area profil
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Xeloda (Gastric Cancer)- Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Xeloda (Gastric Cancer)- Analysis and Forecasts to 2020 provides Xeloda sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2007-2020). The report also includes information on Oncology's Disease market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy ar
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Etoposide (Gastric Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Etoposide (Gastric Cancer) - Analysis and Forecasts to 2020 provides Etoposide sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Oncology's Disease market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope The
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Afinitor (Gastric Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Afinitor (Gastric Cancer) - Analysis and Forecasts to 2020 provides Afinitor sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Oncology's Disease market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.Note: This is a on-deman
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Ramucirumab (Gastric Cancer) - Analysis and Forecast to 2020
GlobalDatas pharmaceuticals report, Ramucirumab (Gastric Cancer) - Analysis and Forecast to 2020 provides Ramucirumab sales forecasts for US, and EU-5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Oncology's Disease market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Thera
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Cisplatin (Gastric Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Cisplatin (Gastric Cancer) Analysis and Forecasts to 2020 provides Cisplatin sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Oncology's Disease market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Thera
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Doxorubicin (Gastric Cancer) - Analysis and Forecast to 2020
GlobalDatas pharmaceuticals report, Doxorubicin (Gastric Cancer) - Analysis and Forecast to 2020 provides Doxorubicin estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Oncology's Disease market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Ther
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Ellence (Gastric Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Ellence (Gastric Cancer) - Analysis and Forecasts to 2020 provides Ellence sales estimates for EU5 . In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2012). The report also includes information on Oncology's Disease market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area profile
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Erbitux (Gastric Cancer)- Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Erbitux (Gastric Cancer)- Analysis and Forecasts to 2020 provides Erbitux sales forecasts for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Oncology's Disease market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope Therapy area pr
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Mitomycin (Gastric Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Mitomycin (Gastric Cancer) - Analysis and Forecasts to 2020 provides Mitomycin sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Oncology's Disease market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Taxotere (Gastric Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Taxotere (Gastric Cancer) - Analysis and Forecasts to 2020 provides Taxotere sales estimates for US, EU5 and Japan . In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Oncology's Disease market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Vectibix (Gastric Cancer) - Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Vectibix (Gastric Cancer) - Analysis and Forecasts to 2020 provides Vectibix sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Parkinson's Disease market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts. Scope
Published Date: Oct 2011
Published By: GlobalData

Price: $2000

Back To Top